Cantry Medico Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 23.04%
- Profit Growth -76.11%
- Ebitda -230.97%
- Net Worth -52.95%
- Total Assets 39.07%
About Cantry Medico
Cantry Medico Private Limited (CMPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 December 2012 and has a history of 12 years and two months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jitendra Gautam and Shashi Gautam serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24233MH2012PTC238891
-
Company No.
238891
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Dec 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Cantry Medico Private Limited offer?
Cantry Medico Private Limited offers a wide range of products and services, including Amoxicillin drugs, Amoxicillin Potassium Clavulanate Tablet, Multivitamin Tablets & Capsules, Vitamin Tablets & Capsules, Folic Acid Tablet, Antibiotic Tablets & Capsules, Co-Amoxiclav Tablet.
Who are the key members and board of directors at Cantry Medico?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendra Gautam
|
Director | 19-Apr-2013 | Current |
|
Shashi Gautam
|
Director | 25-Jun-2014 | Current |
Financial Performance of Cantry Medico.
Cantry Medico Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.04% increase. The company also saw a substantial fall in profitability, with a 76.11% decrease in profit. The company's net worth observed a substantial decline by a decrease of 52.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cantry Medico?
In 2018, Cantry Medico had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cantry Medico?
Unlock and access historical data on people associated with Cantry Medico, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cantry Medico, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cantry Medico's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
